Hong Kong Stocks Drop 1.47% at Midday as AI Hardware Leads Decline by Over 10%
nashnova research
The Hang Seng Index fell 1.47% to 23,955 at midday on October 15, with the AI hardware sector leading losses of over 10%; hotter-than-expected U.S. inflation, SK Hynix delaying HBM4 equipment orders, and Chinese smartphone shipments hitting a 13-year low combined to pressure sentiment.
Why did AI hardware fall the hardest?
U.S. September CPI came in above expectations, raising fears of a longer rate-hike cycle — when borrowing costs rise, the companies priced on future earnings get their valuations cut first.
This means → the sell-off is not about AI itself breaking down; it is about the cost of capital squeezing valuation froth.
Adding to the pain: SK Hynix reportedly delayed some HBM4 (next-generation high-bandwidth memory) back-end equipment orders, dragging supply-chain sentiment — Yangtze Optical Fibre (長飛光纖光纜) fell over 13%, Montage Technology (澜起科技) over 11%, ASMPT over 8%.
Why did the smartphone supply chain sell off too?
Q3 China smartphone shipments hit a 13-year low year-on-year; global shipments also dropped sharply.
In plain terms = phones are not selling, and the pain runs from assembly all the way down to components.
FIT Hon Teng (鸿腾精密) fell 7% and FIH Mobile (富智康集团) fell 5%, with losses concentrated in contract manufacturing and parts.
Why are base metals and lithium batteries also falling?
Base metals: hotter CPI → higher rate-hike bets → stronger dollar → dollar-denominated commodities under pressure. MMG (五矿资源) fell 6%, CMOC (洛阳钼业) fell 5%.
Lithium batteries: a cut in export tax rebates weakened expectations for finished-vehicle exports; the market fears the pressure will travel up the chain — vehicles → batteries → upstream lithium. CATL (宁德时代) fell 6%, CALB (中创新航) fell 4%.
This reflects a single underlying signal from two different sectors: the macro environment is tightening, and demand is cooling.
Was anything bucking the trend?
Hengrui Medicine (恒瑞医药) rose over 3% after its self-developed Alzheimer's drug SHR-3201 injection was approved for clinical trials — a company-specific catalyst, unrelated to the broader market.
Guoen Technology (国恩科技) rebounded over 12% following a profit alert: estimated first-three-quarter net profit up as much as 78.84% year-on-year.
In plain terms = today's gainers are riding their own catalysts, not a market turn.
What to watch this afternoon?
Morning turnover hit HK$113.8 billion — not thin, which means the selling is backed by real volume, not a low-liquidity drift lower.
The Hang Seng Tech Index widened its loss to 2.94%, falling harder than the broader index; tech sentiment is the most fragile.
This means → whether AI hardware and the smartphone chain can stabilize this afternoon is the key tell for Hong Kong's near-term direction — continued heavy selling would push the window for a short-term bounce further out.
市场有风险，内容仅供研究参考，不构成投资建议。